Develop, manufacture, and sell genomic analysis oncology diagnostics
Food and Drug Administration regulatory policy generally and policy for approval of new oncology diagnostic technologies
Reimbursement for new oncology diagnostic technologies generally, including public and private payers
HCR - Health Issues
ARENTFOX SCHIFF LLP
1717 K Street, NW, Washington, DC, 20006, US
DAN RENBERG